Zanganeh Mahkam — SEC insider filings

SEC reporting owner CIK 1507650. 39 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2020-11-13 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Summit Therapeutics Inc. (SMMT)Co-Chief Executive Officer, Director, 10% owner2519 legs · 57,642,692 sh · $115,433,797—31
PULSE BIOSCIENCES, INC. (PLSE)Director14——34

Insider filings — Zanganeh Mahkam

FiledFormIssuerReported transactionsSource
2026-11-204Summit Therapeutics Inc. (SMMT)Option exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0EDGAR
2026-11-164Summit Therapeutics Inc. (SMMT)Option exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0EDGAR
2026-06-154PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 14,504 (derivative) @ $0EDGAR
2026-06-124Summit Therapeutics Inc. (SMMT)Purchase (P): 3,810,000 @ $13.12EDGAR
2026-06-044Summit Therapeutics Inc. (SMMT)Purchase (P): 100,000 @ $14.60EDGAR
2026-01-064Summit Therapeutics Inc. (SMMT)Grant/award (A): 11,232 (derivative) @ $8.76EDGAR
2025-10-234Summit Therapeutics Inc. (SMMT)Grant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74 · Grant/award (A): 13,980,789 @ $18.74EDGAR
2025-09-114Summit Therapeutics Inc. (SMMT)Purchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07EDGAR
2025-08-194PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 24,134 (derivative) @ $0EDGAR
2025-06-024Summit Therapeutics Inc. (SMMT)Option exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0EDGAR
2025-05-014Summit Therapeutics Inc. (SMMT)Grant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative)EDGAR
2025-04-094Summit Therapeutics Inc. (SMMT)Option exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0EDGAR
2025-02-114PULSE BIOSCIENCES, INC. (PLSE)Option exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 (derivative) @ $0 · Option exercise/expiry (X): 30,121 (derivative) @ $0EDGAR
2025-01-064Summit Therapeutics Inc. (SMMT)Grant/award (A): 10,724 (derivative) @ $9.18EDGAR
2024-10-034Summit Therapeutics Inc. (SMMT)Option exercise/expiry (X): 315,681 @ $1.58 · Option exercise/expiry (X): 315,681 (derivative) @ $0EDGAR
2024-09-134Summit Therapeutics Inc. (SMMT)Grant/award (A): 44,052 @ $22.70EDGAR
2024-08-234Summit Therapeutics Inc. (SMMT)Grant/award (A): 260,000 (derivative) · Grant/award (A): 100,000 (derivative) · Grant/award (A): 2,397,640 (derivative)EDGAR
2024-08-134PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-07-094PULSE BIOSCIENCES, INC. (PLSE)Option exercise/expiry (X): 60,242 · Purchase (P): 30,121 (derivative) · Purchase (P): 30,121 (derivative)EDGAR
2024-06-244Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 8,247 (derivative) @ $0EDGAR
2024-03-274Summit Therapeutics Inc. (SMMT)Purchase (P): 26,000 @ $3.72 · Purchase (P): 34,321 @ $3.72 · Purchase (P): 30,000 @ $3.75 · Purchase (P): 20,000 @ $3.71EDGAR
2023-12-134Summit Therapeutics Inc. (SMMT)Option exercise/expiry (X): 489,814 @ $1.44 · Purchase (P): 5,000 @ $2.07 · Option exercise/expiry (X): 315,681 @ $1.58 · Option exercise/expiry (X): 489,814 (derivative) @ $0 · Option exercise/expiry (X): 315,681 (derivative) @ $0EDGAR
2023-11-154Pulse Biosciences, Inc. (PLSE)Option exercise (M): 20,000 @ $2.14 · Option exercise (M): 56,075 @ $2.14 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 56,075 (derivative) @ $0EDGAR
2023-10-164Summit Therapeutics Inc. (SMMT)Grant/award (A): 11,988,198 (derivative)EDGAR
2023-07-064/APulse Biosciences, Inc. (PLSE)Option exercise/expiry (X): 86,668 @ $2.05 · Option exercise/expiry (X): 86,668 (derivative) @ $0EDGAR
2023-06-134Pulse Biosciences, Inc. (PLSE)Option exercise/expiry (X): 86,668 @ $2.05 · Option exercise/expiry (X): 86,668 (derivative) @ $0EDGAR
2023-06-064Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 20,168 (derivative) @ $0EDGAR
2023-03-134/ASummit Therapeutics Inc. (SMMT)Purchase (P): 16,778,415 @ $1.05 · Purchase (P): 6,748,629 @ $1.05EDGAR
2023-03-084Summit Therapeutics Inc. (SMMT)Purchase (P): 15,973,743 @ $1.05 · Purchase (P): 804,672 @ $1.05 · Purchase (P): 6,748,629 @ $1.05EDGAR
2022-12-094Summit Therapeutics Inc. (SMMT)Other (J): 373,857EDGAR
2022-08-184Summit Therapeutics Inc. (SMMT)Purchase (P): 184,430 @ $0.97 · Purchase (P): 4,593,777 @ $0.97 · Purchase (P): 1,030,925 @ $0.97EDGAR
2022-06-104Pulse Biosciences, Inc. (PLSE)Option exercise/expiry (X): 86,668 · Purchase (P): 86,668 (derivative)EDGAR
2022-05-234Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 56,075 (derivative) @ $0EDGAR
2021-12-174Summit Therapeutics Inc. (SMMT)Grant/award (A): 15,000 (derivative)EDGAR
2021-05-214Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 8,026 (derivative) @ $0EDGAR
2021-05-144Summit Therapeutics Inc. (SMMT)Purchase (P): 389,077 @ $5.24EDGAR
2021-01-214Pulse Biosciences, Inc. (PLSE)Option exercise/expiry (X): 3,000 @ $7.01 · Option exercise/expiry (X): 307 @ $7.01 · Option exercise/expiry (X): 3,000 (derivative) @ $0 · Option exercise/expiry (X): 307 (derivative) @ $0EDGAR
2020-11-244Summit Therapeutics Inc. (SMMT)Grant/award (A): 2,400,000 (derivative)EDGAR
2020-11-134Summit Therapeutics Inc. (SMMT)Grant/award (A): 200,000 (derivative) · Grant/award (A): 3,323 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1507650 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs